Clin2
NCT07591883Possibly a fitNot yet recruiting

Herbal medicine for recent ischemic stroke

Ischemic StrokesTraditional Chinese Medicine (TCM)Prognosis

Part of Brain & nervous system, Heart & circulation clinical trials.

This study tests a traditional Chinese medicine (herbal) treatment for people who have had a recent acute ischemic stroke. It will see if the herbal medicine helps improve recovery and how it works in the body, potentially offering a new treatment option.

Summary written for real people, not researchers, by Clin2.

Phase
Phase 2/Phase 3
Enrollment
358 people
Ages
18 years and older
Study type
Interventional

Who can take part

  • You must be at least 18 years old.
  • You need to have had an acute ischemic stroke (a stroke caused by a blocked blood vessel) with symptoms starting within the last 48 hours.
  • Your stroke must be moderately severe, as evaluated by a standard stroke scale.
  • You must be able to consent to the study and be willing to participate.
  • You cannot have had severe disability before the stroke, recent major procedures for the stroke (like thrombectomy), or serious heart, liver, kidney, or lung disease.
  • You must not be pregnant or nursing.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT06883110Recruiting
Testing traditional Chinese medicine for recent stroke

This trial tests whether a traditional Chinese medicine (Angong Niuhuang pill) made from different sources of a natural ingredient can help people who recently had a moderate stroke caused by a blood clot. It aims to see if the pill can improve recovery.

Wuhan, Hubei
NCT06342206Recruiting
TCM Assessment for Recent Ischemic Stroke

This study uses traditional Chinese medicine (TCM) diagnostic tools to evaluate patients who had an ischemic stroke within the last 10 days. It aims to understand the acute and chronic phases of stroke to help guide future treatments.

Changhua
NCT07003386Recruiting· Phase 2/Phase 3
Galantamine for recent ischemic stroke

This trial tests a plant-based medicine called galantamine, given within 3 days of an ischemic stroke, to see if it helps recovery. It combines Western and Traditional Chinese Medicine approaches and aims to understand how the treatment works.

Shanghai, Shanghai Municipality
NCT05046106Not yet recruiting· Phase 2/Phase 3
Herbal medicine for stroke recovery

This study tests an herbal medicine (MLC1501) to see if it helps people recover better after a stroke. If you join, you'll take the medicine or a placebo (a pill with no active ingredient) while doing rehabilitation, and the study will track your recovery over time.

NCT07690020Not yet recruiting
Herbal capsule for recent ischemic stroke recovery

This trial tests whether a Chinese herbal capsule (Getong Tongluo) can improve recovery after a recent ischemic stroke. It may help reduce disability by protecting brain cells and improving blood flow.

NCT07121088Not yet recruiting· Phase 4
Traditional Chinese medicine for stroke with diabetes

This study tests whether traditional Chinese medicine can help people who recently had a stroke and also have type 2 diabetes. It aims to see if adding this treatment improves recovery compared to standard care.

Hear when a new Traditional Chinese Medicine (TCM) trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.